CN101052370A
|
|
Wetting agent containing monoester and diester composition based on butanediol
|
FR2865131A1
|
|
USE OF AN EXTRACT OF ACMELLA OLERACEA FOR ITS BOTOX LIKE EFFECT IN AN ANTI-WRINKLE COSMETIC COMPOSITION
|
AU2003302209A1
|
|
Use of 2-hydroxymethyltetrahydropyran as excipient in a pharmaceutical or cosmetic composition
|
AU2003303900A1
|
|
Cosmetic composition based on cirsimarin
|
AU2003302211A1
|
|
A composition comprising an extract of the buds of castanea sativa and cosmetic uses thereof
|
FR2850272A1
|
|
EXTRACT OF CRYPTOMERIA JAPONICA BUDS
|
AU7854601A
|
|
Method for coating solid particles with a thermofusible agent, and resulting coated solid particles
|
US6375987B1
|
|
Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix
|
US6312704B1
|
|
Orally administrable composition capable of providing enhanced bioavailability when ingested
|
WO0032163A1
|
|
Walnut seed meal extract
|
WO0024385A1
|
|
Tablet for crunching with masked taste and instant release of active principle and method for making same
|
EP1087757A1
|
|
Method for making tablets with active principle sustained-release
|
EP1058540A1
|
|
Oral pellet with immediate release comprising glycerides subjected to polyglycolysis, method for making same
|
AU1881899A
|
|
Composition for cosmetic, dietetic or pharmaceutical use
|
EP0975324A1
|
|
Anti-desquamative cosmetic composition and method for making said composition
|
KR20000048761A
|
|
Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix
|
US6054136A
|
|
Orally administrable composition capable of providing enhanced bioavailability when ingested
|
US5998392A
|
|
Benzoyl peroxide flocculent materials and methods of their preparation
|
EP0699433A2
|
|
Cosmetic or pharmaceutical composition containing chitosan derivatives
|
EP0670715A1
|
|
Oral delivery composition forming a microemulsion
|